Glucocorticoid therapy-induced memory deficits: acute versus chronic effects
- PMID: 18367613
- PMCID: PMC6670588
- DOI: 10.1523/JNEUROSCI.4893-07.2008
Glucocorticoid therapy-induced memory deficits: acute versus chronic effects
Abstract
Conditions with chronically elevated glucocorticoid levels are usually associated with declarative memory deficits. Considerable evidence suggests that long-term glucocorticoid exposure may cause cognitive impairment via cumulative and long-lasting influences on hippocampal function and morphology. However, because elevated glucocorticoid levels at the time of retention testing are also known to have direct impairing effects on memory retrieval, it is possible that such acute hormonal influences on retrieval processes contribute to the memory deficits found with chronic glucocorticoid exposure. To investigate this issue, we examined memory functions and hippocampal volume in 24 patients with rheumatoid arthritis who were treated either chronically (5.3 +/- 1.0 years, mean +/- SE) with low to moderate doses of prednisone (7.5 +/- 0.8 mg, mean +/- SE) or without glucocorticoids. In both groups, delayed recall of words learned 24 h earlier was assessed under conditions of either elevated or basal glucocorticoid levels in a double-blind, placebo-controlled crossover design. Although the findings in this patient population did not provide evidence for harmful effects of a history of chronic prednisone treatment on memory performance or hippocampal volume per se, acute prednisone administration 1 h before retention testing to either the steroid or nonsteroid group impaired word recall. Thus, these findings indicate that memory deficits observed under chronically elevated glucocorticoid levels result, at least in part, from acute and reversible glucocorticoid effects on memory retrieval.
Figures
Similar articles
-
A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes.J Affect Disord. 2013 Sep 5;150(2):551-8. doi: 10.1016/j.jad.2013.01.038. Epub 2013 Feb 28. J Affect Disord. 2013. PMID: 23453674 Free PMC article. Clinical Trial.
-
Suppressing the morning rise in cortisol impairs free recall.Learn Mem. 2010 Mar 24;17(4):186-90. doi: 10.1101/lm.1728510. Print 2010 Apr. Learn Mem. 2010. PMID: 20335371 Clinical Trial.
-
Cortisol's effects on hippocampal activation in depressed patients are related to alterations in memory formation.J Psychiatr Res. 2011 Jan;45(1):15-23. doi: 10.1016/j.jpsychires.2010.10.005. J Psychiatr Res. 2011. PMID: 21220074 Free PMC article. Clinical Trial.
-
Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe.Eur J Neurosci. 2003 Mar;17(6):1296-302. doi: 10.1046/j.1460-9568.2003.02542.x. Eur J Neurosci. 2003. PMID: 12670318
-
Glucocorticoid-induced inhibition of memory retrieval: implications for posttraumatic stress disorder.Ann N Y Acad Sci. 2006 Jul;1071:216-20. doi: 10.1196/annals.1364.016. Ann N Y Acad Sci. 2006. PMID: 16891572 Review.
Cited by
-
Association between myasthenia gravis and Alzheimer's disease.Rev Neurol. 2024 Jan 16;78(2):41-46. doi: 10.33588/rn.7802.2023120. Rev Neurol. 2024. PMID: 38223947 Free PMC article. English, Spanish.
-
Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis.Clin Rheumatol. 2019 Jul;38(7):1851-1856. doi: 10.1007/s10067-019-04488-3. Epub 2019 Mar 8. Clin Rheumatol. 2019. PMID: 30848400
-
High postoperative serum cortisol level is associated with increased risk of cognitive dysfunction early after coronary artery bypass graft surgery: a prospective cohort study.PLoS One. 2013 Oct 15;8(10):e77637. doi: 10.1371/journal.pone.0077637. eCollection 2013. PLoS One. 2013. PMID: 24143249 Free PMC article.
-
Corticosteroid-related central nervous system side effects.J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S94-8. doi: 10.4103/0976-500X.120975. J Pharmacol Pharmacother. 2013. PMID: 24347992 Free PMC article.
-
Cognitive performance in patients with Myasthenia Gravis: an association with glucocorticosteroid use and depression.Dement Neuropsychol. 2020 Jul-Sep;14(3):315-323. doi: 10.1590/1980-57642020dn14-030013. Dement Neuropsychol. 2020. PMID: 32973985 Free PMC article.
References
-
- Bermond B, Surachno S, Lok A, ten Berge IJ, Plasmans B, Kox C, Schuller E, Schellekens PT, Hamel R. Memory functions in prednisone-treated kidney transplant patients. Clin Transplant. 2005;19:512–517. - PubMed
-
- Bijlsma JW, Saag KG, Buttgereit F, Da Silva JA. Developments in glucocorticoid therapy. Rheum Dis Clin North Am. 2005;31:1–17. - PubMed
-
- Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, Rusinek H, Wisniewski HM. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience. 2000;95:721–725. - PubMed
-
- Brown ES, Woolston J, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein J, Babcock E, Cullum CM. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55:538–545. - PubMed
-
- Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S. Effect of corticosteroids on short-term and long-term memory. Neurology. 2005;64:335–337. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical